Acute massive pulmonary embolism (PE) is a life-threatening condition that requires prompt and aggressive interventions, including anticoagulation, catheter-directed thrombolysis (CDT), mechanical thrombectomy, or surgical thromboembolectomy. The aim of this study was to evaluate the treatment outcome in patients with massive PE who were treated with either ultrasound-accelerated thrombolysis using the EkoSonic Endovascular System (EKOS) or CDT intervention. During a recent 10-year period, the clinical records of all patients with massive PE undergoing catheter-directed interventions were evaluated. Patients were divided into two treatment groups: EKOS versus CDT interventions. Comparisons were made with regard to the treatment outcome between the two groups. Twenty-five patients underwent 33 catheter-directed interventions for massive PE during the study period. Among them, EKOS or CDT was performed in 15 (45%) and 18 (55%) procedures, respectively. In the EKOS group, complete thrombus removal was achieved in 100% cases. In the CDT cohort, complete or partial thrombus removal was accomplished in 7 (50%) and 2 (14%) cases, respectively. Comparing treatment success based on thrombus removal, EKOS treatment resulted in an improved treatment outcome compared with the CDT group (p ≤ .02). The mean time of thrombolysis in EKOS and CDT group was 17.4 ± 5.23 and 25.3 ± 7.35 hours, respectively (p = .03). The mortality rate in the EKOS and CDT group was 9.1% and 14.2%, respectively (not significant). Treatment-related hemorrhagic complication rates in the EKOS and CDT group were 0% and 21.4%, respectively (p = .02). A significant reduction in Miller scores was noted in both groups following catheter-based interventions. No significant difference in relative Miller score improvement was observed between groups. Ultrasound-accelerated thrombolysis using the EkoSonic system is an effective treatment modality in patients with acute massive PE. When compared with CDT, this treatment modality provides similar treatment efficacy with reduced thrombolytic infusion time and treatment-related complications.
Hamilton-CraigCR, McNeilK, DunningJ. Treatment options and strategies for acute severe pulmonary embolism. Intern Med J2008; 38: 657–67.
2.
ZamanianRT, GouldMK. Effectiveness and cost effectiveness of thrombolysis in patients with acute pulmonary embolism. Curr Opin Pulm Med2008; 14: 422–6.
3.
GoldhaberSZ, VisaniL, De RosaM. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet1999; 353: 1386–9.
4.
VedanthamS. Interventional approaches to acute venous thromboembolism. Semin Respir Crit Care Med2008; 29: 56–65.
5.
FerreiraG, CarsonJL. Clinical prediction rules for the diagnosis of pulmonary embolism. Am J Med2002; 113: 337–8.
6.
CarsonJL, KelleyMA, DuffA. The clinical course of pulmonary embolism. N Engl J Med1992; 326: 1240–5.
7.
KuoWT, van den BoschMA, HofmannLV. Catheter-directed embolectomy, fragmentation, and thrombolysis for the treatment of massive pulmonary embolism after failure of systemic thrombolysis. Chest2008; 134: 250–4.
8.
DoumaRA, KamphuisenPW. Thrombolysis for pulmonary embolism and venous thrombosis: Is it worthwhile?Semin Thromb Hemost2007; 33: 821–8.
9.
SegalJB, StreiffMB, HofmannLV. Management of venous thromboembolism: A systematic review for a practice guideline. Ann Intern Med2007; 146: 211–22.
10.
Jerjes-SanchezC, Ramirez-RiveraA, de Lourdes GarciaM. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial. J Thromb Thrombolysis1995; 2: 227–9.
11.
HumeM. Thrombolysis of the experimental radioactive pulmonary embolus. Its demonstration with the use of several agents. N Engl J Med1961; 264: 471–5.
12.
AgnelliG, BecattiniC, KirschsteinT. Thrombolysis vs heparin in the treatment of pulmonary embolism: A clinical outcome-based meta-analysis. Arch Intern Med2002; 162: 2537–41.
13.
KonstantinidesSV. Massive pulmonary embolism: What level of aggression?Semin Respir Crit Care Med2008; 29: 47–55.
14.
TorbickiA, PerrierA, KonstantinidesS. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J2008; 29: 2276–315.
15.
ChechiT, VecchioS, SpazianiG. Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism. Catheter Cardiovasc Interv2009; 73: 506–13.
16.
SpiesC, KhandelwalA, SmithTH. Percutaneous mechanical thrombectomy for massive pulmonary embolism using a conservative treatment strategy. J Interv Cardiol2008; 21: 566–71.
17.
KucherN, GoldhaberSZ. Mechanical catheter intervention in massive pulmonary embolism: Proof of concept. Chest2008; 134: 2–4.
18.
MargheriM, VittoriG, VecchioS. Early and long-term clinical results of AngioJet rheolytic thrombectomy in patients with acute pulmonary embolism. Am J Cardiol2008; 101: 252–8.
19.
MyatA, AhsanA. Percutaneous mechanical thrombectomy for the treatment of acute massive pulmonary embolism: Case report. Thromb J2007; 5: 20.
20.
CasazzaF, RonconL, GrecoF. Pulmonary embolism: Treatment of the acute episode. Ital Heart J2005; 6: 818–23.
21.
BiedererJ, SchoeneA, ReuterM. Suspected pulmonary artery disruption after transvenous pulmonary embolectomy using a hydrodynamic thrombectomy device: Clinical case and experimental study on porcine lung expiants. J Endovasc Ther2003; 10: 99–110.
22.
DwarkaD, SchwartzSA, SmythSH, O'BrienMJ. Bradyarrhythmias during use of the AngioJet system. J Vasc Interv Radiol2006; 17: 1693–5.
23.
KarnabatidisD, KatsanosK, KagadisGC, SiablisD. Re: Bradyarrhythmias during use of the AngioJet system. J Vasc Interv Radiol2007; 18: 937.
24.
KumarN, JanjigianY, SchwartzDR. Paradoxical wors-ening of shock after the use of a percutaneous mechanical thrombectomy device in a postpartum patient with a massive pulmonary embolism. Chest2007; 132: 677–9.
25.
SiablisD, KarnabatidisD, KatsanosK. AngioJet rheolytic thrombectomy versus local intrapulmonary thrombolysis in massive pulmonary embolism: A retrospective data analysis. J Endovasc Ther2005; 12: 206–14.
MahonBR, NesbitGM, BarnwellSL. North American clinical experience with the EKOS MicroLy-sUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol2003; 24: 534–8.
29.
ParikhS, MotarjemeA, McNamaraT. Ultrasound-accelerated thrombolysis for the treatment of deep vein thrombosis: Initial clinical experience. J Vasc Interv Radiol2008; 19: 521–8.
30.
ChamsuddinA, NazzalL, KangB. Catheter-directed thrombolysis with the Endowave system in the treatment of acute massive pulmonary embolism: A retrospective multicenter case series. J Vasc Interv Radiol2008; 19: 372–6.
31.
MillerGA, SuttonGC, KerrIH. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Heart J1971; 33: 616.
32.
KasperW, KonstantinidesS, GeibelA. Management strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry. J Am Coll Cardiol1997; 30: 1165–71.
33.
LeeS, SongSW, YiG. Open pulmonary thromboembolectomy in patients with major pulmonary thromboembolism. Yonsei Med J2008; 49: 973–7.
34.
ThistlethwaitePA, KanekoK, MadaniMM, JamiesonSW. Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg2008; 14: 274–82.
35.
QuirozR, KucherN, SchoepfUJ. Right ventricular enlargement on chest computed tomography: Prognostic role in acute pulmonary embolism. Circulation2004; 109: 2401–4.
36.
GoldhaberSZ. The current role of thrombolytic therapy for pulmonary embolism. Semin Vasc Surg2000; 13: 217–20.
37.
GoldhaberSZ. Evolving concepts in thrombolytic therapy for pulmonary embolism. Chest1992; 101: 183S–5S.
VerstraeteM, MillerGA, BounameauxH. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation1988; 77: 353–60.
40.
AnselGM, BottiCFJr, SilverMJ. Treatment of acute limb ischemia with a percutaneous mechanical thrombectomy-based endovascular approach: 5-year limb salvage and survival results from a single center series. Catheter Cardiovasc Interv2008; 72: 325–30.
41.
CynamonJ, PierpontCE. Thrombolysis for the treatment of thrombosed hemodialysis access grafts. Rev Cardiovasc Med2002; 3 Suppl 2: S84–91.
WangF, WangC, WangT. [Experimental study of the thrombolytic effects in a canine model of pulmonary thromboembolism induced by autologous radioactive blood clots]. Zhonghua Jie He He Hu Xi Za Zhi2004; 27: 93–6.
44.
FrancisCW, BlincA, LeeS, CoxC. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol1995; 21: 419–24.
45.
BlincA, FrancisCW, TrudnowskiJL, CarstensenEL. Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood1993; 81: 2636–43.
46.
FrancisCW, OnundarsonPT, CarstensenEL. Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest1992; 90: 2063–8.
47.
NahirnyakVM, YoonSW, HollandCK. Acousto-mechanical and thermal properties of clotted blood. J Acoust Soc Am2006; 119: 3766–72.
48.
HardigBM, PerssonHW, GidoG, OlssonSB. Does low-energy ultrasound, known to enhance thrombolysis, affect the size of ischemic brain damage?J Ultrasound Med2003; 22: 1301–8.
49.
SuchkovaV, CarstensenEL, FrancisCW. Ultrasound enhancement of fibrinolysis at frequencies of 27 to 100 kHz. Ultrasound Med Biol2002; 28: 377–82.
50.
GuX, SharafuddinMJ, TitusJL. Acute and delayed outcomes of mechanical thrombectomy with use of the steerable Amplatz thrombectomy device in a model of subacute inferior vena cava thrombosis. J Vasc Interv Radiol1997; 8: 947–56.
51.
SharafuddinMJ, HicksME, JensonML. Rheolytic thrombectomy with use of the AngioJet-F105 catheter: Preclinical evaluation of safety. J Vasc Interv Radiol1997; 8: 939–45.
52.
TrerotolaSO, McLennanG, DavidsonD. Preclinical in vivo testing of the Arrow-Trerotola percutaneous thrombolytic device for venous thrombosis. J Vasc Interv Radiol2001; 12: 95–103.
53.
MewissenMW, SeabrookGR, MeissnerMH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: Report of a national multicenter registry. Radiology1999; 211: 39–49.
54.
Gouin-ThibaultI, PautasE, SiguretV. Safety profile of different low-molecular weight heparins used at therapeutic dose. Drug Saf2005; 28: 333–49.
55.
KearonC. Long-term management of patients after venous thromboembolism. Circulation2004; 110: 110–8.
